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Abstract
Nucleoside triphosphate diphosphohydrolases 1, 2, 3 and 8 (NTPDases 1, 2, 3 and 8) are the dominant ectonucleo-
tidases and thereby expected to play important roles in nucleotide signaling. Distinct biochemical characteristics of
individual NTPDases should allow them to regulate P2 receptor activation differentially. Therefore, the biochemical and
kinetic properties of these enzymes were compared. NTPDases 1, 2, 3 and 8 efficiently hydrolyzed ATP and UTP with
Km values in the micromolar range, indicating that they should terminate the effects exerted by these nucleotide agonists
at P2X1Y7 and P2Y2,4,11 receptors. Since NTPDase1 does not allow accumulation of ADP, it should terminate the
activation of P2Y1,12,13 receptors far more efficiently than the other NTPDases. In contrast, NTPDases 2, 3 and 8 are
expected to promote the activation of ADP specific receptors, because in the presence of ATP they produce a sustained
(NTPDase2) or transient (NTPDases 3 and 8) accumulation of ADP. Interestingly, all plasma membrane NTPDases
dephosphorylate UTP with a significant accumulation of UDP, favoring P2Y6 receptor activation. NTPDases differ in
divalent cation and pH dependence, although all are active in the pH range of 7.0Y8.5. Various NTPDases may also
distinctly affect formation of extracellular adenosine and therefore adenosine receptor-mediated responses, since they
generate different amounts of the substrate (AMP) and inhibitor (ADP) of ecto-5¶-nucleotidase, the rate limiting enzyme
in the production of adenosine. Taken together, these data indicate that plasma membrane NTPDases hydrolyze
nucleotides in a distinctive manner and may therefore differentially regulate P2 and adenosine receptor signaling.
Abbreviations: E-NTPDase – ecto-nucleoside triphosphate diphosphohydrolase; HPLC–high-performance liquid chroma-
tography; PCR–polymerase chain reaction; RT–reverse transcription
Introduction
Ectonucleotidases control the level of nucleotides at the
cell surface by breaking down these molecules [1]. The
biologically most relevant substrates of these enzymes,
ATP, ADP, UTP and UDP, initiate a number of cellular
responses via the selective activation of ionotropic P2X
and metabotropic P2Y receptors [2, 3]. Therefore, ectonu-
cleotidases may dictate a number of physiological
responses by regulating P2 receptor activation.
Members of the ecto-nucleoside triphosphate diphospho-
hydrolase (E-NTPDase) family are dominant ectonucleo-
tidases [1]. Four out of the eight members of this family,
namely NTPDase1, NTPDase2, NTPDase3 and NTPDase8,
appear relevant to the control of P2 receptor signaling since
they are located at the surface of the plasma membrane
and hydrolyze nucleotides in the range of concentration
that activates P2 receptors [4Y8]. NTPDases 1, 2, 3 and
8 have two plasma membrane spanning domains with an
active site facing the extracellular milieu [1, 8]. In contrast,
NTPDases 4Y7 are anchored to the membranes of intracel-
lular organelles by one (NTPDases 5 and 6) or two
(NTPDases 4 and 7) transmembrane domains and their
catalytic site faces the lumen of intracellular compartments
such as the Golgi apparatus and the endoplasmatic retic-
ulum [9Y16]. Even though NTPDases 5 and 6 can be
present at the surface of the plasma membrane and secreted
as soluble enzymes following a proteolytic cleavage, their
high Km values and low specific activities [11, 12, 14, 15]
make it unlikely that these enzymes regulate P2 receptor
signaling.
NTPDases dephosphorylate a variety of nucleoside
triphosphates (e.g. ATP and UTP) and diphosphates (e.g.,
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the presence of divalent cations (Ca
2+ or Mg
2+). Among
the plasma membrane bound NTPDases (NTPDases 1, 2, 3
and 8), NTPDase1 (also named CD39, ATPDase, ecto-
apyrase, ecto-ADPase) [17Y20] hydrolyzes ATP and ADP
equally, NTPDase2 (ecto-ATPase, CD39Ll) [6, 21Y23] is
a preferential triphosphonucleosidase whereas NTPDase3
(CD39L3, HB6) [24] and NTPDase8 [8] are functional
intermediates between NTPDases 1 and 2.
So far, the comparison of the biochemical properties of
plasma membrane NTPDases is difficult as these enzymes
were in general partially characterized, came from different
species and were studied in different laboratories with
different conditions and techniques. To better understand
the potential roles of these enzymes in the control of P2
receptor signaling, and the different expression of various
NTPDases in mammals, we have compared the biochem-
ical properties of plasma membrane bound NTPDases from
human and mouse. Our results indicate that these enzymes
have the capacity to collaborate distinctly with P2 receptors
either by terminating the stimulation of some of them or by
providing the diphosphonucleoside ligands for other P2
receptors. These data also suggest that plasma membrane
NTPDases may influence differently the formation of
adenosine, and therefore adenosine receptor activation.
Materials and methods
Materials
Agarose, aprotinin, ethylene glycol-bis(2-aminoethyl-
ether)-N-N-N ¶-N ¶-tetraacetic acid (EGTA), nucleotides,
phenylmethanesulfonyl fluoride (PMSF), sodium acetate,
and tetrabutylammonium hydrogen sulphate (TBA) were
purchased from Sigma-Aldrich (Oakville, Ontario, Can-
ada). Bis(2-hydroxyethyl)aminoYtris(hydroxymethyl)
methane) (BisYTris), ethylenediaminetetraacetic acid
(EDTA), and tris(hydroxymethyl)aminomethane (Tris)
were provided by EMD Chemicals (Gibbstown, New
Jersey, USA). All cell culture media were obtained from
Invitrogen (Burlington, Ontario, Canada).
Methods
Plasmids
The plasmids encoding human NTPDasel (GenBank accession
no. U87967) [18], human NTPDase2 (NM_001246) [23],
human NTPDase3 (AF034840) [24], mouse NTPDase1
(NM_009848) [25], mouse NTPDase3 (AY376710) [7] and
mouse NTPDase8 (AY364442) [8] have all been described in
published reports. The plasmid encoding rat NTPDase8
corresponds to GenBank accession no. AY536920 (manuscript
in preparation).
Mouse NTPDase2 was cloned as follows. Total RNA was
isolated from mouse heart with Trizol reagent (Invitrogen).
The complementary DNA was synthesized with Superscript
II(Invitrogen)from 500 ng of total RNA with oligo(dT)18 as
the primer, in accordance with manufacturer’s instructions
(Invitrogen). For amplification, 10% of the reverse tran-
scription (RT) reaction was used as template in a final
volume of 50 ml reaction mixture containing 0.6 mM
primer, 400 mM dNTP and 3.5 U Expand High Fidelity
PCR System (Roche, Laval, Canada). The following sets of
primers were designed based on the 5¶ and 3¶ ends of mouse
NTPDase2 published sequences (AK002553 and
NM_009849): Set 1 forward 5¶GGG-GTC-CCT-GCT-GTG-
TTC3¶ and reverse 5¶CCG-AGG-GCA-TCT-CTG-ACC3¶;
set 2 forward 5¶TCC-CTG-CTG-TGT-TCT-CCC-G3¶ and
reverse 5¶TGA-AGC-AGC-CTG-GAC-GGT-C3¶. Amplifica-
t i o nw a ss t a r t e db ya ni n c u b a t i o no f2m i na t9 4-Cw h i c h
was followed by 30 cycles of 1 min denaturation at 94 -C,
1 min annealing at 60 -C and 2 min primer extension at
72 -C and ending with 7 min incubation at 72 -C. The
PCR product of approximately 1.8 kb was purified on
agarose gel using the QIAEX II gel extraction kit (Qiagen,
Mississauga, Canada) and ligated into the expression
vector pcDNA3.1/V5-His (Invitrogen). Plasmid DNA was
purified with QIAprep Spin Miniprep kit (Qiagen) and
orientation of the insert was verified by restriction
mapping. One clone obtained with each set of primers
was amplified and fully sequenced in one direction. Both
sequences were identical. The corresponding and combined
sequence is given in accession number AY37674. The
clone obtained with the first set of primers was used for
transfection and activity assays.
Cell transfection and protein preparation
COS-7 cells were transfected in 10 cm plates using
Lipofectamine (Invitrogen), as previously described [18].
Briefly, 80%Y90% confluent cells were incubated for 5 h at
37 -C in Dulbecco’s modified Eagle’s medium (DMEM) in
the absence of fetal bovine serum (FBS) with 6 mgo f
plasmid DNA and 24 ml of Lipofectamine reagent. The
reaction was stopped by the addition of an equal volume
of DMEM containing 20% FBS and the cells were
harvested 40Y72 h later. For the preparation of protein
extracts, transfected cells were washed three times with
Tris-saline buffer at 4 -C collected by scraping in the
harvesting buffer (95 mM NaCl, 0.1 mM PMSF and 45
mM Tris at pH 7.5) and washed twice by 300  g
centrifugation for 10 min at 4 -C. Cells were resuspended
in the harvesting buffer containing 10 mg/ml aprotinin and
sonicated. Nucleus and cellular debris were discarded by
centrifugation at 300  g for 10 min at 4 -C and the
supernatant (crude protein extract), was aliquoted and
stored at j80 -C until used for activity assays. Protein
concentration was estimated by the Bradford microplate
assay using bovine serum albumin as a standard [26].
NTPDase activity measurement
Enzyme activity of protein extracts was determined as
previously described [19]. NTPDase activity was measured
at 37 -C in 0.5 ml of the following incubation medium: 5
mM CaCl2 and 80 mM Tris, pH 7.4 or as indicated. Protein
extracts were added to the incubation mixture and pre-
incubated at 37 -C for 3 min. The reaction was initiated
by the addition of 25 m1 of substrate to give a final
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0.125 ml of malachite green reagent. The liberated
inorganic phosphate (Pi) was measured according to
Baykov et al. [27]. In the kinetic determinations, less than
10% of substrate was hydrolyzed over the course of the
reaction to ensure the conditions of initial velocity and to
minimize ADP and UDP hydrolysis in experiments with
ATP and UTP as substrates. Kinetic parameters (Km and
Vmax) were calculated using GraphPad Prism software
(GraphPad Software, San Diego, California, USA).
NTPDase activity at the surface of intact COS-7 cells
transfected with expression vectors containing NTPDases
1, 2, 3 or 8 was measured in 24-well plate in the presence
of 5 mM CaCl2, 145 mM NaCl, 0.5 mM nucleotides, and
100 mM Tris at pH 7.4. The activity obtained with the
control cells was subtracted from the one obtained with
NTPDase transfected cells.
Optimum pH was determined in the presence of 2 mM
CaCl2 in the following buffer: 50 mM BisYTris, 50 mM
Tris, 50 mM glycine (pH 4.0Y11.0). In parallel, it was also
measured in the following individual buffers: 100 mM
acetate for pH 4.0Y5.5, 100 mM MES for pH 5.5Y7.0, 100
mM Tris for pH 7.0Y9.0 and 100 mM glycine for pH
9.0Y11.0 as described previously [7, 8]. In some experi-
ments 1 mM CaCl2 was substituted by 1 mM MgCl2.I n
control assays, 1 mM EDTA plus 1 mM EGTA replaced
CaCl2 and MgCl2 to remove traces of endogenous divalent
cations from the medium. One unit of enzyme activity
corresponds to the release of 1 mmol Pi/min at 37 -C. All
experiments were performed in triplicate with controls
Figure 1. Substrate specificity of plasma membrane bound NTPDases. The assays for the enzymatic activity were carried out with protein extracts
from transiently transfected COS-7 cells in the presence of 0.5 mM adenine or uracil nucleotide with either 1 mM CaCl2 (open bars) or 1 mM MgCl2
(solid bars), as described under Materials and methods. The average T SEM of two to five experiments performed in triplicate is shown.
P2 receptor agonist hydrolysis by NTPDases 195where the protein extract was added after the reaction had
been stopped.
Separation and quantification of nucleotides by HPLC
For HPLC analysis, NTPDase activity assays were per-
formed as described above with the following modifica-
tions. Aliquots of 40 ml of reaction mixture were taken at
different time points and transferred to an equal volume of
ice-cold 1 M perchloric acid. The samples were centrifuged
for 5 min at 1,000  g at 4 -C. Supernatants were
neutralized with 1 M KOH (4 -C), centrifuged for a
subsequent 5 min at 1,000  g and lipids extracted with
n-heptane (5:1, v/v). An aliquot of 20 ml of the resulting
samples was used for nucleotide analysis by HPLC.
Adenine nucleotides (ATP, ADP and AMP) were sepa-
ratedona15cm4.6mm,3mmSUPELCOSILiLC-18-T
column (Supelco, Bellefonte, Pennsylvania, USA) with a
mobile phase composed of 25 mM TBA, 5 mM EDTA, 100
mM KH2PO4/K2HPO4, pH 7.0 and 2% methanol (v/v), at a
flow rate of 1 ml/min. Uracil nucleotides (UTP, UDP and
UMP) were resolved using SUPELCOSILi LC-18-T
column (25 cm  4.6 mm, 5 mm, Supelco) as described
above except the mobile phase did not contain methanol.
Samples containing both adenine and uracil nucleotides
were analyzed with the latter column with a mobile phase
composed of 16.7 mM TBA, 3.3 mM EDTA, 66.7 mM
KH2PO4/K2HPO4, pH 7.0 at the flow rate of 1 ml/min. The
nucleotides were detected by UV absorption at 260 nm and
identified and quantified by the comparison of the retention
time with the appropriate standards.
Results
Biochemical characterization of plasma membrane
bound NTPDases
The biochemical characteristics of human and murine
plasma membrane bound NTPDases (members 1, 2, 3 and
8) were studied using protein extracts of COS-7 cells
transiently transfected with an expression vector (pcDNA3)
containing cDNA that encodes each enzyme. Time course
analysis revealed that for all NTPDases tested, the reaction
was linear for at least first 30 min with either ATP or ADP
as a substrate (data not shown). To ensure the linearity of
the reaction, the subsequent enzymatic assays were carried
out for 10Y20 min. Figure 1 shows that all plasma
membrane bound NTPDases hydrolyze tri- and diphospho-
nucleosides that have capability to induce a P2 receptor
response, namely ATP, ADP, UTP and UDP. NTPDases 1,
2, 3 and 8 all preferred tri- over diphosphonucleosides,
although with different NTP/NDP ratios as determined by
the measurement of Pi release (Table 1). None of these
enzymes hydrolyzed AMP (data not shown).
All human and murine NTPDases required Mg
2+ or Ca
2+
ions for their activity with optimal concentration between
l and 5 mM (data not shown). Indeed, in the presence of 1
mM EDTA and 1 mM EGTA to chelate divalent cations,
no activity could be detected (data not shown). Figure 1
shows that Ca
2+ was preferred over Mg
2+ by NTPDases 3
and 8, while there were less differences for NTPDases 1
and 2. Interestingly, all plasma membrane NTPDases
hydrolyzed uracil nucleotides more efficiently in the
presence of Ca
2+. For few enzymes and substrates tested,
the NTP/NDP ratio slightly changed when Ca
2+ was
replaced by Mg
2+ (Figure 1 and Table 1).
Figure 2 shows the effect of pH on both ATPase and
ADPase activities of plasma membrane NTPDases. In
parallel, we determined the effect of pH using individual
buffers and we obtained similar patterns to those depicted
in Figure 2 (data not shown). All NTPDases were active
(9 60% maximal activity) in physiological to slightly
basic pH range (7.0Y8.5) except rat NTPDase8 with ADP
as a substrate. Nevertheless, there were some important
differences. By considering the activity greater than 50%
of the maximal activity, NTPDase1 was active in neutral
to alkaline pHs [7Y10], NTPDases 2 and 8 were active at
more acidic pHs from 4.5 to 8.5, while NTPDase3 hy-
drolyzed substrates over a broad range of pH spanning
from 4.5 to 11. Among the NTPDases analyzed, NTPDase8
hydrolyzed nucleotides with the highest velocity at acidic
pHs (pH 4Y6) while NTPDase3 was the most efficient at
alkaline pHs (pH 9Y11). Figure 2 also shows some rela-
tively minor variations between human and murine
NTPDases. The most significant difference was observed
with NTPDase2 where the optimal pH of activity for ATP
hydrolysis was pH 6.0 for human NTPDase2 and pH 8.0
for mouse NTPDase2. Another peculiarity was the peak of
activity at pH 5.0, that was observed with mouse
NTPDase3 but not with the human (Figure 2) and rat (data
not shown) NTPDase3.
Table 1. NTP/NDP ratios of human and murine plasma membrane
NTPDases.
Enzyme Cation Human or rat
a Mouse
ATP/ADP ratio
NTPDase l Ca
2+ 1.8 T 0.1 1.6 T 0.2
Mg
2+ 1.9 T 0.1 1.9 T 0.1
NTPDase 2 Ca
2+ 7.2 T 1.8 9.5 T 1.8
Mg
2+ 3.5 T 1.0 11.8 T 2.4
NTPDase 3 Ca
2+ 4.3 T 0.1 2.1 T 0.4
Mg
2+ 2.9 T 0.1 2.8 T 0.3
NTPDase 8 Ca
2+ 2.2 T 0.1
a 1.4 T 0.1
Mg
2+ 4.1 T 0.7
a 3.1 T 1.2
UTP/UDP ratio
NTPDase l Ca
2+ 1.7 T 0.1 1.8 T 0.7
Mg
2+ 1.9 T 0.4 2.6 T 0.5
NTPDase 2 Ca
2+ 9.3 T 1.3 15.1 T 4.9
Mg
2+ 12.8 T 2.0 13.4 T 4.5
NTPDase 3 Ca
2+ 6.2 T 0.5 2.4 T 0.8
Mg
2+ 2.8 T 0.5 1.7 T 0.3
NTPDase 8 Ca
2+ 4.8 T 0.2
a 1.9 T 0.2
Mg
2+ 9.2 T 2.4
a 1.7 T 0.4
Enzyme activity assays were carried out with protein extracts from
transiently transfected COS-7 cells in 80 mM Tris, pH 7.4 with either 1
mM CaCl2 or 1 mM MgC12. Reactions were started by the addition of 0.5
mM nucleotide as a substrate and Pi release measured as indicated in
Materials and methods. Results are expressed as the mean T SD of at least
two experiments performed in triplicate.
aRat NTPDase8.
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bound NTPDases
All NTPDases analyzed exhibited MichaelisYMenten ki-
netics for the hydrolysis of ATP, ADP, UTP and UDP (data
not shown). Apparent kinetic constants were calculated
according to WoolfYAugustinssonYHofstee plot and are
summarized in Table 2.
Although human and mouse NTPDasel had similar Km
values for P2 receptor agonists, all human NTPDases
tested had higher Km values than the ones corresponding to
their mouse orthologue. The hydrolysis pattern and
intermediate products of ATP and UTP dephosphorylation
were also analyzed for each of these enzymes by HPLC.
This technique, in contrast to Pi determination by calori-
metric assays, distinguishes between the di- and mono-
phosphonucleoside products of ATP and UTP degradation
and also enables one to follow the simultaneous hydrolysis
of ATP and UTP. HPLC analysis of adenine and uracil
nucleotide hydrolysis was performed with either intact
COS-7 cells transfected with mouse NTPDases 1, 2, 3 and
8 or protein extracts of these cells (Figure 3 and data not
shown for intact cells). As the pattern of hydrolysis was
similar in both cases, we conducted all other experiments
with protein extracts of transfected COS-7 cells.
Of physiological interest, human and mouse NTPDase1
hydrolyzed ATP to AMP with a very modest appearance of
ADP (Figure 3a). UTP was also hydrolyzed by both
enzymes with a major difference that UDP accumulated
in the medium and was hydrolyzed only when UTP levels
Figure 2. The effect of pH on plasma membrane NTPDases. Enzyme activity assays with protein extracts from transiently transfected COS-7 cells
were carried out in 50 mM BisYTris, 50 mM Tris, 50 mM Glycine, 2 mM CaCl2 at the indicated pH. Reaction were initiated with 0.5 mM ATP (&)o r
ADP (Ì). A representative of at least three independent experiments performed in triplicate is shown.
P2 receptor agonist hydrolysis by NTPDases 197were significantly decreased (Figure 3b). Combined ATP
and UTP hydrolysis showed that adenine nucleotides are
better substrates than uracil nucleotides for both
NTPDase1s, which was in agreement with the Km values
measured for these nucleotides (Table 2, Figure 3c).
Both human and mouse NTPDase2 hydrolyzed ATP and
UTP efficiently to the corresponding diphosphonucleoside
(Figure 3). A small accumulation of AMP was also
observed for the hydrolysis of ATP that was a little higher
with the human enzyme (Figure 3a). This and other slight
differences between human and murine NTPDases may be
attributable to some variations in the substrate preferences
between enzymes from different species or may have also
resulted from differences in the amount of activity used for
the HPLC determination of the hydrolysis pattern. Com-
pared to human NTPDases 1, 2, 3 and rat NTPDase8, half
as many units of activity were used for mouse NTPDases
with a doubled reaction time. The simultaneous hydrolysis
of ATP and UTP by human NTPDase2 showed that this
enzyme preferred adenine nucleotides over uracil nucleo-
tides, as expected from the apparent Km and Vmax values
(Table 2, Figure 3). This could not have been predicted by
considering only the profile of substrate specificity
depicted in Figure 1. In contrast, mouse NTPDase2 had
similar Km and Vmax for ATP and UTP and hydrolyzed
these nucleotides with no preferences (Table 2, Figure 3).
Human and mouse NTPDase3, as well as murine
NTPDase8, hydrolyzed ATP and UTP with an important
but transient formation of the respective diphosphonucleo-
side (Figure 3). Among these four enzymes, only mouse
NTPDase3 hydrolyzed adenine and uracil nucleotides
without any preferences (Figure 3), as expected from the
apparent Km and Vmax values. In contrast, human
NTPDase3 and murine NTPDase8 dephosphorylated ADP
to AMP much faster than UDP to UMP, leading to an
important and sustained accumulation of UDP (Figures 3b,
c). Interestingly, human NTPDase3 had lower Km for ADP
than for ATP but the former was a much poorer substrate,
as suggested by its low Vmax. The pattern of hydrolysis of
500 mM ATP (Figure 3a) and 25 mM ATP (data not shown)
was similar in both cases.
Discussion
This work reports the comparison of the biochemical
properties and kinetics of hydrolysis of P2 receptor
agonists by human and murine plasma membrane bound
NTPDases. As the presence of detergents changes the
biochemical properties of NTPDases we used membrane
preparations of transiently transfected COS-7 cells. The
protein extracts from these cells have only background
levels of nucleotidase activity and allow the analysis of
NTPDases in their native membrane bound forms. For all
assays performed, the results obtained with protein extracts
were similar to those obtained with intact transfected cells.
Although with different abilities, all NTPDases tested
hydrolyzed tri- and diphosphonucleosides relevant to P2
receptor signaling. In general, human and murine
NTPDases had similar substrate specificity (Figure 1).
Only human NTPDase2 hydrolyzed ADP slightly more
than its mouse counterpart. For comparison, it has been
previously reported that mammalian NTPDase2 hydrolyses
triphosphonucleosides preferentially by 10- to 40-fold
while NTPDases 1, 3, and 8 hydrolyze tri- and diphospho-
nucleosides efficiently with ATP:ADP ratios of õ1Y2:1,
õ3Y4:1 and õ2:1, respectively (for references, see Table 3).
It is well known that divalent cations such as Mg
2+ and
Ca
2+ are essential for nucleotide hydrolysis by NTPDases
[1]. Our results showed that NTPDases 1 and 2 had no clear
preferences with respect to Ca
2+ or Mg
2+ ions, whereas
NTPDases 3 [28] and 8 preferred Ca
2+ for the hydrolysis of
both tri- and diphosphonucleosides. Interestingly, uracil
nucleotides were hydrolyzed more efficiently in the
presence of Ca
2+ by all plasma membrane NTPDases.
Even though all NTPDases tested were highly active
at physiological pH, our studies indicated differences
between these enzymes. NTPDase1 had the narrowest range
Table 2. Kinetic parameters of human and murine NTPDases.
Enzyme ATP ADP UTP UDP
Km
(mM)
Vmax
(U/mg prot.)
Km
(mM)
Vmax
(U/mg prot.)
Km
(mM)
Vmax
(U/mg prot.)
Km
(mM)
Vmax
(U/mg prot.)
hNTPDase1 17 T 1 0.94 T 0.02 22 T 1 0.75 T 0.01 47 T 4 1.05 T 0.03 135 T 10 0.79 T 0.04
hNTPDase2 70 T 2 2.3 T 0.03 ND ND 393 T 30 3.9 T 0.2 ND ND
hNTPDase3 75 T 10 0.79 T 0.03 31 T 1 0.18 T 0.01 58 T 6 0.57 T 0.03 67 T 3 0.17 T 0.01
rNTPDase8 46 T 5 0.74 T 0.04 265 T 20 0.61 T 0.03 124 T 10 1.17 T 0.06 1780 T 140 1.37 T 0.08
mNTPDase1 12 T 1 1.78 T 0.04 13 T 1 1.12 T 0.02 49 T 2 4.0 T 0.11 92 T 6 2.15 T 0.09
mNTPDase2 37 T 2 1.7 T 0.05 ND ND 49 T 2 3.9 T 0.1 ND ND
mNTPDase3
a 11 T 2 0.35 T 0.02 19 T 2 0.2 T 0.01 10 T 1 0.3 T 0.01 27 T 2 0.14 T 0.01
mNTPDase8
b 13 T 6 0.82 T 0.02 41 T 6 0.95 T 0.08 47 T 1 1.13 T 0.02 171 T 15 1.08 T 0.02
Reactions were carried out for 10 min in the presence of 5 mM CaCl2 and 80 mM Tris buffer pH 7.4 or 100 mM MES pH 6.4 for mouse NTPDase8. In
all assays, less than 10% of the substrate was hydrolyzed. Km and Vmax values were estimated with nucleotide concentration ranging from 0.02 to 1.5
mM by regression analysis of WoolfYAugustinssonYHofstee plots using GraphPad Prism software. Results are expressed as the mean T SEM of three
separate experiments, each performed in triplicate.
aFrom Lavoie et al. [7].
bReprinted from Bigonnesse et al. [8], Copyright 2004 American Chemical Society.
ND: not determined as diphosphonucleosides are poor substrates of NTPDase2.
198 F. Kukulski et al.of pH for 9 50% maximal activity in the physiological to
basic conditions (pH 7Y9.5). In comparison, NTPDases 2
and 8 were efficient from acidic to slightly basic pHs
(4.5Y8.5) while NTPDase3 appeared to be fairly active in
the entire pH range tested (4.5Y11). Depending on the
localization of NTPDases, these characteristics may have
physiological importance. Before the nomenclature of
NTPDases was established, pH optima between 7 and
8 for ATP hydrolysis and 7.5Y9 for ADP hydrolysis were
reported for enzymes assigned with different names, which
Figure 3. Profiles of nucleotide hydrolysis by plasma membrane NTPDases. Reactions were initiated by the addition of protein extracts from COS-7
cells transfected with plasmid encoding an NTPDase to a medium containing 0.5 mM ATP and/or UTP, 5 mM CaCl2 and 80 mM Tris, pH 7.4. Tris was
replaced by 80 mM MES pH 6.4 for mouse NTPDase8. A sample of protein extracts was added to obtain 24 nmol/min of activity with ATP as a substrate
of human NTPDases 1, 2, 3 and rat NTPDase8, and of 10Y12 nmol/min of all mouse NTPDases. This amount of activity was doubled when both
substrates (ATP and UTP) were added together. Controls with protein extracts from COS-7 cells not expressing NTPDase activities were performed and
their activity subtracted from the activity of samples containing NTPDases. Aliquots were taken at the indicated time points and the reaction was stopped
immediately by the addition of an equal volume of ice-cold 1 M perchloric acid. These samples were prepared and analyzed for nucleotide contents by
HPLC, as described under Materials and methods. Data from a representative experiment performed in triplicate is given. (a) ATP hydrolysis by human
and murine NTPDases: ATP (&), ADP (Í), AMP (r). (b) UTP hydrolysis by NTPDases: UTP ()), UDP (Ì), UMP (¸). (c) Simultaneous hydrolysis
of ATP and UTP by NTPDases: ATP (&), ADP (Í), AMP (r), UTP ()), UDP (Ì), UMP (¸). *From Lavoie et al. [7].
#Reprinted from Bigonnesse et
al. [8], Copyright 2004 American Chemical Society.
P2 receptor agonist hydrolysis by NTPDases 199most likely correspond to NTPDase1 ([29] and references
therein). More recently, pH optima in physiological range
for synaptosomal NTPDasel and NTPDase2 were reported
[30] in agreement with what we observed for the
recombinant human and mouse orthologues.
The comparison between Km values of plasma mem-
brane NTPDases and EC50 of nucleotide receptors is of
physiological importance as it provides information on
which of these enzymes can regulate a particular P2
receptor function. Our results show that all apparent Km
constants of human and murine NTPDases obtained for
adenine nucleotides as substrates were in the low mi-
cromolar range with the exception of rat NTPDase8 with
ADP as a substrate (265 mM). Higher Km values were
obtained for the hydrolysis of uracil nucleotides with
human NTPDase1 (UDP) and NTPDase2 (UTP), rat
NTPDase8 (both UTP and UDP) and mouse NTPDase1 and
NTPDase8 (UDP). Micromolar Km values were also pre-
viously reported for NTPDases (Table 3). However, these
experiments were performed with enzymes from different
species, purified to different extent and with different
detergents, or from intact cells or protein extracts from
Figure 3. Continued.
200 F. Kukulski et al.different transfected cell lines. Therefore, the comparison
of the kinetic properties of these ectonucleotidases is
virtually impossible. Importantly, the apparent Km values
of all human and murine NTPDases measured were
consistent with the hydrolysis pattern of ATP and UTP,
except for human NTPDase3. ADP and UDP had respec-
tively higher and equal affinity for human NTPDase3
compared to ATP and UTP. In this case, however, the Km
values are less important, because ADP and UDP are poor
substrates of human NTPDase3, as reflected by the low
Vmax values of their hydrolysis compared to Vmax of ATP
and UTP hydrolysis, respectively. Accordingly, ADP and
UDP accumulation was observed during ATP and UTP
hydrolysis by human NTPDase3. The same explanation
would also apply to the hydrolysis of ATP by porcine
NTPDase2 (Table 3). It was also noteworthy that the
profiles of nucleotide hydrolysis together with Km mea-
surements provide valuable information about nucleotide
hydrolysis compared to the simple profile of substrate
specificity that may sometimes lead to erroneous conclu-
sions. For example, the latter suggests that UTP is a better
substrate than ATP for human NTPDase2 (Figure 1) while
the HPLC pattern of hydrolysis showed that ATP is
preferred over UTP (Figure 3c).
Figure 3. Continued.
P2 receptor agonist hydrolysis by NTPDases 201Some slight variations were found in the pattern of
nucleotide hydrolysis between NTPDase orthologues. As it
was previously shown for rat NTPDase1 [21], mouse and
human NTPDase1 hydrolyze ATP to AMP with the
liberation of two molecules of Pi. However, a modest and
transient accumulation of ADP could be detected for
human and mouse NTPDase1 that was not observed during
ATP hydrolysis by rat NTPDase1. These results are
consistent with the observation that pig pancreas ATPDase
(truncated form of NTPDase1) hydrolyzed ATP in a step
favored manner; ATP to AMP via ADP [31]. Another
minor variance observed between human NTPDases 2 and
3, and their murine orthologues was their preference for
adenine to uracil nucleotides as substrates.
Although there were some minor differences between
NTPDases from different species, their main pattern of
substrate hydrolysis remained largely similar. We may
therefore expect that these enzymes would regulate P2
receptor signaling in the same way in different species.
NTPDase1 would terminate the effects exerted by either
ATP or UTP on P2X1Y7 and P2Y2,4,11,o rA D Po n
P2Y1,12,13 receptors. Indeed, endothelial NTPDase1 was
shown to prevent ADP-induced platelet aggregation in the
blood (via P2Y1 and P2Y12) [18, 20, 32Y34] and to keep
platelets functional by preventing P2Y1 receptor desensiti-
zation [25]. By generating UDP from UTP, NTPDase1
may also favor the transient activation of P2Y6 receptor or
may also terminate it, depending on the magnitude and
identity of nucleotide release. NTPDase2 would be
expected to terminate P2X1Y7 and P2Y2,4,11 receptor
activation and simultaneously provide ligands for receptors
stimulated by diphosphonucleosides (P2Y1,6,12,13). This
potential function of NTPDase2 was corroborated by an
in vitro aggregation assay where its activity facilitated
platelet aggregation by generating ADP in the presence of
ATP [35]. NTPDase3 and NTPDase8, which efficiently
hydrolyze ATP and UTP, may attenuate and/or terminate
the activation of receptors for these two nucleotides
(P2X1Y7 and P2Y2,4,11), but also favor the activation of
ADP and UDP specific receptors (P2Y1,6,12,13), as they
produce a transient accumulation of diphosphonucleosides.
NTPDases 1, 8 and human NTPDase3, which hydrolyze
UDP poorly compared to ADP, would be expected to
maintain a prolonged activation of P2Y6 receptor. This
could be of potential interest in inflammation, as for
example UDP was shown to promote IL-8 secretion in
human monocytic cells by the activation of P2Y6 [36].
AMP, the end product of ATP hydrolysis by NTPDases
1, 3 and 8, is further dephosphorylated by ecto-5¶-
nucleotidase (CD73) to adenosine, a biologically active
molecule that exerts a diversity of physiological responses
via its own receptors [37Y39]. Our data suggest that
Table 3. Biochemical and kinetic parameters of recombinant and purified plasma membrane NTPDases.
a
Enzyme Species Source (detergent used) Kinetic parameters ATP/ADP
Ratio
b
Ion
preference
Reference
ATP ADP
Km
(mM)
Vmax
(U/mg prot.)
Km
(mM)
Vmax
(U/mg prot.)
NTPDasel Mouse Rec., extract of COS-7 cells 1.4 [35]
Rat Rec., intact CHO cells 1.3 [21]
Rec., extract of COS-7 cells 75 1.7 [40]
Human Pur., placenta (Triton X-100) 10 20 1.1 Ca
2+ 9 Mg
2+ [41]
Rec., extract of COS-7 cells 1.3 [35]
Porcine Pur., brain (Polydocanol) 97 65 95 47 1.4 Mg
2+: ATP [30]
Ca
2+: ADP
Bovine Pur., aorta (Triton X-100)
c 14 16.3 (õ20%) 12 16.2 (õ20%) 1.1 [4]
Pur., heart (Triton X-100) 29 1.1 Ca
2+ $ Mg
2+ [42]
NTPDase2 Rat Rec., extract of COS-7 cells 40 [35]
Rec., intact CHO cells 20Y30 [43]
Rec., extract of COS-7 cells 11 [44]
Human Rec., extract of HeLa cells 210
d 22
d [23]
Rec., intact NIH-3T3 cells 400 0.107
e 102 0.004
e 9.4 [6]
Porcine Pur., brain (Polydocanol) 270 76 6 6 12 Mg
2+: ADP [30]
Ca
2+: ADP
Rabbit Pur., muscle (Digitonin)
f 6600
d 20
d Mg
2+
NTPDase3 Human Rec., extract of COS-1 cells 7
d,g 2
d 23
d,g 0.5
d 3.6Y4.2
d Ca
2+ 9 Mg
2+ [5, 28]
hATPDase Porcine Pur., liver (Triton X-100) 93 8.5
(õ5%Y20%)
108 8.5
(õ5%Y20%)
1.1 Ca
2+ 9 Mg
2+ [45]
Rec.: recombinant enzyme expressed in cell line; Pur.: homogenous or highly purified enzyme with the estimated purity given in parentheses.
aIn the presence of Ca
2+ ions, unless stated otherwise.
bRatios with concentration of substrate of at least five times the Km of the indicated enzyme corresponding to concentrations of 100Y2,500 mM.
cThis enzyme was identified as NTPDase1 from the biochemical properties and partial amino acid internal sequences.
dExperiments carried out with 5 mM Mg
2+.
eActivity per 1 million cells.
fThis enzyme was identified as NTPDase2 from the biochemical properties and N-terminal sequence.
gDr. T.L. Kirley (personal communication).
202 F. Kukulski et al.NTPDases may have a different impact on the formation of
adenosine. NTPDase1 that hydrolyzes ATP to AMP
without any significant accumulation of ADP should
facilitate fast appearance of adenosine. In contrast, since
ecto-5¶-nucleotidase is inhibited by ADP [37], it is
expected that the formation of adenosine would be
prevented in the presence of NTPDase2 alone and delayed
in the presence of NTPDases 3 or 8. Indeed, the latter
enzymes would be expected to generate a time lapse
between the activation of P2 receptors and the subsequent
activation of adenosine receptors as they require more time
to produce the substrate (AMP) of CD73 and remove its
inhibitor (ADP).
In summary, NTPDases have the potential to exert a
tight, distinct and sophisticated regulation of P2 and
adenosine receptor signaling, and therefore affect a number
of biological functions. The results presented in this work
in conjunction with the localization of these enzymes will
help define the functions of cell surface NTPDases.
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